Drugs & TargetsFree Stanford partners with Notable and Tempus to make rapid personalized treatment in blood cancer patients April 19, 2019Vol.45 No.16
Drugs & TargetsFree OncoSec anounces collaboration with Duke to study TAVO + plasmid DNA vaccines in breast cancer April 19, 2019Vol.45 No.16
Drugs & TargetsFree Roswell Park selects Circuit Clinical as collaborator for CIMAvax clinical trial April 19, 2019Vol.45 No.16
Drugs & Targets FDA expands pembrolizumab indication for first-line treatment of NSCLC April 12, 2019Vol.45 No.15
Drugs & Targets American Cancer Society study shows need to better identify who may not benefit from aggressive treatment April 12, 2019Vol.45 No.15
Drugs & TargetsFree Varian ARIA Oncology Information System awarded CancerLinQ certification April 05, 2019Vol.45 No.14
Drugs & TargetsFree FDA expands use of metastatic breast cancer treatment to include male patients April 05, 2019Vol.45 No.14
